Načítá se...
Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia
BACKGROUND: Some hospital patients may be at risk of or may present with major bleeding. Abnormalities of clotting (coagulation) are often recorded in these people, and the traditional management has been with transfusions of blood components, either to prevent bleeding (prophylactic) or to treat bl...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517302/ https://ncbi.nlm.nih.gov/pubmed/30582172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010649.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|